Collectively, our data identify a novel and important role of HIPK1 in pathological cardiac hypertrophy and suggest that targeting HIPK1 is a promising therapeutic strategy to attenuate pathological cardiac hypertrophy and heart failure (Figure7). This evidence concerns the gene HIPK1 and heart failure.